サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1287550

女性の健康診断市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測

Women's Health Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 143 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
女性の健康診断市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測
出版日: 2023年03月18日
発行: IMARC
ページ情報: 英文 143 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

女性の健康診断の世界市場規模は、2022年に236億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に7.51%の成長率（CAGR）を示し、2028年までに373億米ドルに達すると予測しています。

女性の健康診断薬は、女性患者の生物学的および心理社会的なさまざまな状態の診断に役立ちます。性的な問題や膣の問題、妊娠の合併症に対処し、骨粗しょう症や更年期障害、乳がんや子宮頸がんなどの脅威となる病気を管理するのに役立つのです。生検、超音波検査、化学療法、磁気共鳴画像法（MRI）など、一連の高度な実験室検査、ツール、処置に依存しています。現在、いくつかのヘルスケア診断センターは、女性に影響を与えるまれな病気や症状の診断と管理を強化するために、広範な臨床検査ソリューションを提供しています。

女性の健康診断の市場動向：

女性の全体的な幸福に影響を与える健康問題の有病率の上昇は、市場にプラスの影響を与える主要な要因の1つです。さらに、健康意識の高まりと、早期診断の利点に関する意識の高まりが、世界中でポイントオブケア（POC）型女性の健康診断の需要を喚起しています。また、ストレスの多いライフスタイルやアルコール・薬物摂取の増加による不妊症の増加も、妊娠合併症に対処し、より健康な生活を送るための女性の健康診断の必要性を高めています。さらに、更年期は心血管疾患や尿失禁など特定の疾患の発症リスクを高めるため、50歳以上の女性人口が大幅に増加し、市場の成長に寄与しています。これに加えて、いくつかの調査では、女性はホルモンの変化により、うつ病や不安神経症などの精神疾患を経験しやすいと結論付けられています。このことは、女性のメンタルヘルスを改善するために多くの国の保健機関が行っているいくつかの取り組みと相まって、全世界で市場の成長を促進しています。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者について
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 予測手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 女性の健康診断薬の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 タイプ別市場内訳

  • 診断用デバイス
    • 市場動向
    • 主要セグメント
      • 生検装置
      • 画像診断・モニタリング装置
      • アクセサリ・消耗品
    • 市場予測
  • 診断テスト
    • 市場動向
    • 主要セグメント
      • 乳がん検査
      • PAPスメア検査とHPV検査
      • 妊娠検査薬・排卵検査薬
      • その他
    • 市場予測

第7章 用途別の市場内訳

  • 乳がん
    • 市場動向
    • 市場予測
  • 感染症検査
    • 市場動向
    • 市場予測
  • 骨粗鬆症検査
    • 市場動向
    • 市場予測
  • 妊娠・不妊検査
    • 市場動向
    • 市場予測
  • 性感染症検査
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 エンドユーザー別市場内訳

  • 病院・診断センター
    • 市場動向
    • 市場予測
  • ホームケア
    • 市場動向
    • 市場予測

第9章 地域別市場内訳

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋地域
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 国別市場内訳
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の度合い
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Becton Dickinson and Company
    • bioMerieux SA
    • Cardinal Health Inc.
    • Cook Group Incorporated
    • F. Hoffmann-La Roche AG
    • General Electric Company
    • Hologic Inc.
    • Koninklijke Philips N.V.
    • Perkinelmer Inc.
    • Quest Diagnostics Inc.
    • Siemens AG
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Women's Health Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Women's Health Diagnostics Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Women's Health Diagnostics Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Women's Health Diagnostics Market: Breakup by Type (in %), 2022
  • Figure 5: Global: Women's Health Diagnostics Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Women's Health Diagnostics Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Women's Health Diagnostics Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Women's Health Diagnostics (Diagnostic Devices) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Women's Health Diagnostics (Diagnostic Devices) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Women's Health Diagnostics (Diagnostic Tests) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Women's Health Diagnostics (Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Women's Health Diagnostics (Breast Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Women's Health Diagnostics (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Women's Health Diagnostics (Infectious Disease Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Women's Health Diagnostics (Infectious Disease Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Women's Health Diagnostics (Osteoporosis Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Women's Health Diagnostics (Osteoporosis Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Women's Health Diagnostics (Pregnancy and Fertility Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Women's Health Diagnostics (Pregnancy and Fertility Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Women's Health Diagnostics (Sexually Transmitted Disease Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Women's Health Diagnostics (Sexually Transmitted Disease Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Women's Health Diagnostics (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Women's Health Diagnostics (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Women's Health Diagnostics (Hospital and Diagnostics Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Women's Health Diagnostics (Hospital and Diagnostics Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Women's Health Diagnostics (Home Care) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Women's Health Diagnostics (Home Care) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: North America: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: North America: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: United States: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: United States: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Canada: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Canada: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Asia-Pacific: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Asia-Pacific: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: China: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: China: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Japan: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Japan: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: India: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: India: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: South Korea: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: South Korea: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Australia: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Australia: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Indonesia: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Indonesia: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Others: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Others: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Europe: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Europe: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Germany: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Germany: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: France: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: France: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: United Kingdom: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: United Kingdom: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Italy: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Italy: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Spain: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Spain: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Russia: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Russia: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Others: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Others: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Latin America: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Latin America: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Brazil: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Brazil: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Mexico: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Mexico: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Others: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Others: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Middle East and Africa: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Middle East and Africa: Women's Health Diagnostics Market: Breakup by Country (in %), 2022
  • Figure 76: Middle East and Africa: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Global: Women's Health Diagnostics Industry: SWOT Analysis
  • Figure 78: Global: Women's Health Diagnostics Industry: Value Chain Analysis
  • Figure 79: Global: Women's Health Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Women's Health Diagnostics Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Women's Health Diagnostics Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 3: Global: Women's Health Diagnostics Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Women's Health Diagnostics Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Women's Health Diagnostics Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Women's Health Diagnostics Market: Competitive Structure
  • Table 7: Global: Women's Health Diagnostics Market: Key Players
目次
Product Code: SR1623A308_Report

The global women's health diagnostics market size reached US$ 23.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 37.3 Billion by 2028, exhibiting a growth rate (CAGR) of 7.51% during 2023-2028.

Women's health diagnostics help diagnose various biological and psychosocial conditions of female patients. They assist in addressing sexual and vaginal issues and pregnancy complications and managing threatening diseases, such as osteoporosis, menopause, and certain cancers like breast and cervical. They rely on a series of advanced laboratory tests, tools, and procedures, which include biopsy, ultrasound, chemotherapy, and magnetic resonance imaging (MRI). Several healthcare diagnostics centers are currently offering an expansive range of laboratory testing solutions to enhance the diagnosis and management of rare diseases and conditions that affect women.

Women's Health Diagnostics Market Trends:

The rising prevalence of health issues that impact the overall well-being of women represents one of the major factors influencing the market positively. Moreover, the growing health consciousness, along with the increasing awareness about the benefits of early diagnosis, is catalyzing the demand for point-of-care (POC) women's health diagnostics across the globe. Apart from this, the rising rate of infertility on account of stressful lifestyles and the growing consumption of alcohol and drugs is driving the need for women's health diagnostics to address pregnancy complications and ensure a healthier life. Furthermore, as menopause can increase the risk of developing certain medical conditions, including cardiovascular diseases and urinary incontinence, a significant rise in the female population which is over 50 years is contributing to the market growth. Besides this, several research studies have concluded that women are more likely to experience psychiatric disorders, such as depression and anxiety, during hormonal changes. This, in confluence with several initiatives undertaken by health agencies of numerous countries to improve mental health of women, is propelling the market growth across the globe.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global women's health diagnostics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, application and end user.

Breakup by Type:

Diagnostic Devices

Biopsy Device

Imaging and Monitoring Devices

Accessories and Consumables

Diagnostic Tests

Breast Cancer Testing

PAP Smear and HPV Test

Pregnancy Testing and Ovulation Testing

Others

Breakup by Application:

Breast Cancer

Infectious Disease Testing

Osteoporosis Testing

Pregnancy and Fertility Testing

Sexually Transmitted Disease Testing

Others

Breakup by End User:

Hospital and Diagnostics Centers

Home Care

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, bioMerieux SA, Cardinal Health Inc., Cook Group Incorporated, F. Hoffmann-La Roche AG, General Electric Company, Hologic Inc., Koninklijke Philips N.V., Perkinelmer Inc., Quest Diagnostics Inc., Siemens AG and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

1. What was the size of the global women's health diagnostics market in 2022?

2. What is the expected growth rate of the global women's health diagnostics market during 2023-2028?

3. What are the key factors driving the global women's health diagnostics market?

4. What has been the impact of COVID-19 on the global women's health diagnostics market?

5. What is the breakup of the global women's health diagnostics market based on the type?

6. What is the breakup of the global women's health diagnostics market based on the application?

7. What is the breakup of the global women's health diagnostics market based on the end user?

8. What are the key regions in the global women's health diagnostics market?

9. Who are the key players/companies in the global women's health diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Women's Health Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Diagnostic Devices
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Biopsy Device
      • 6.1.2.2 Imaging and Monitoring Devices
      • 6.1.2.3 Accessories and Consumables
    • 6.1.3 Market Forecast
  • 6.2 Diagnostic Tests
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Breast Cancer Testing
      • 6.2.2.2 PAP Smear and HPV Test
      • 6.2.2.3 Pregnancy Testing and Ovulation Testing
      • 6.2.2.4 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Breast Cancer
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Infectious Disease Testing
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Osteoporosis Testing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Pregnancy and Fertility Testing
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Sexually Transmitted Disease Testing
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospital and Diagnostics Centers
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Home Care
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 bioMerieux SA
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Cardinal Health Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Cook Group Incorporated
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 F. Hoffmann-La Roche AG
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 General Electric Company
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Hologic Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Koninklijke Philips N.V.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Perkinelmer Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Quest Diagnostics Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Siemens AG
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
    • 14.3.13 Thermo Fisher Scientific Inc.
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis